Doug Jacobstein Email

VP, Clinical Development . Provention Bio

Current Roles

Employees:
129
Revenue:
$15.7M
About
Provention Bio, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics aimed at intercepting and preventing immune-mediated diseases. -We seek technologies or targets designed to predict, preempt or intervene before immune disease begins, re-appears or progresses. -We are creating a new biopharmaceutical category for autoimmunity. We leverage a transformational drug development strategy that sources, repositions and advances candidates that: -Target the interception or prevention of immune-mediated disease -Have been underdeveloped or deprioritized because of insufficient clinical trial efficacy or for strategic reasons -Have demonstrated proof-of-mechanism by preventing or intercepting immunopathologic pathways We believe that our deep understanding of immune-mediated pathophysiology, experience in translational medicine, and expertise in the design of rapid go/no-go clinical trials enables us to identify and evaluate potential therapeutic candidates for acquisition or in-licensing.
Provention Bio Address
55 Broad Street
Oldwick, null
Provention Bio Email

Past Companies

Provention BioVP, Clinical Development
Janssen Inc.Director, Immunology Research and Development
Osiris TherapeuticsSenior Director, Clinical Development and Medical Affairs

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.